Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
132.55
-0.13 (-0.10%)
At close: Jun 26, 2026, 4:00 PM EDT
132.56
+0.01 (0.01%)
After-hours: Jun 26, 2026, 7:22 PM EDT
Apogee Therapeutics Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for Apogee Therapeutics stock have an average target of 128.81, with a low estimate of 81 and a high estimate of 140. The average target predicts a decrease of -2.82% from the current stock price of 132.55.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Apogee Therapeutics stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 15 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 3 | 3 | 4 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 19 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Hold Downgrades $133 → $135 | Hold | Downgrades | $133 → $135 | +1.85% | Jun 24, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Downgrades $110 → $135 | Hold | Downgrades | $110 → $135 | +1.85% | Jun 24, 2026 |
| TD Cowen | TD Cowen | Hold Downgrades $133 | Hold | Downgrades | $133 | n/a | Jun 23, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades $160 → $135 | Hold | Downgrades | $160 → $135 | +1.85% | Jun 23, 2026 |
| Citi | Citi | Hold Downgrades $125 → $135 | Hold | Downgrades | $125 → $135 | +1.85% | Jun 23, 2026 |
Financial Forecast
Revenue This Year
8.33M
Revenue Next Year
11.54M
from 8.33M
Increased by 38.46%
EPS This Year
-4.44
from -4.22
EPS Next Year
-5.19
from -4.44
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 100.0M | 100.0M | |
| Avg | 8.3M | 11.5M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 1,100.0% | 3,366.7% |
| Avg | 38.5% | 349.1% |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.25 | -4.36 | |
| Avg | -4.44 | -5.19 | |
| Low | -5.00 | -6.96 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.